Reliv International, Inc  

(Public, NASDAQ:RELV)   Watch this stock  
Find more results for Brett P. Ryan �
1.27
+0.01 (0.79%)
Aug 3 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 1.20 - 1.27
52 week 1.06 - 1.71
Open 1.22
Vol / Avg. 3,473.00/7,427.00
Mkt cap 16.38M
P/E 17.01
Div/yield     -
EPS 0.07
Shares 12.82M
Beta 1.97
Inst. own 7%

Key stats and ratios

Q1 (Mar '15) 2014
Net profit margin 0.79% 1.26%
Operating margin 2.89% 0.17%
EBITD margin - 1.84%
Return on average assets 1.71% 2.66%
Return on average equity 2.74% 4.37%
Employees 208 -
CDP Score - -

Address

136 Chesterfield Industrial Blvd P O Box 405
CHESTERFIELD, MO 63006-0405
United States - Map
+1-636-5379715 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Reliv' International, Inc. is a developer, manufacturer and marketer of a line of nutritional supplements addressing nutrition, specific wellness needs, weight management and sports nutrition. The Company sells its products through an international network marketing system using independent distributors. The Company offers 18 nutritional supplements, a line of five skin care products and a sweetener. The Company's nutritional supplement product line include Reliv Classic and Reliv NOW, two basic nutritional supplements containing a full and balanced blend of vitamins, minerals, protein and herbs; Innergize!, an isotonic sports supplement in two flavors, and FibRestore, a high-fiber and antioxidant supplement. As of December 31, 2014, the Company's network consisted of approximately 47,970 distributors, including 34,650 in the United States and 13,320 across its international markets. The Company manufactures powdered nutritional supplements at its facility in Chesterfield, Missouri.

Officers and directors

Robert L. Montgomery Jr. Chairman of the Board, Chief Executive Officer
Age: 72
Bio & Compensation  - Reuters
Ryan A. Montgomery President
Age: 41
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Carl W. Hastings Ph.D. Vice Chairman of the Board, Chief Scientific Officer
Age: 73
Bio & Compensation  - Reuters
Steven D. Albright Chief Financial Officer, Senior Vice President
Age: 53
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Brett M. Hastings Chief Operating Officer, Senior Vice President
Age: 41
Bio & Compensation  - Reuters
Steven G. Hastings Executive Vice President - Sales and Marketing
Age: 49
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
R. Scott Montgomery Executive Vice President
Age: 45
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Stephen M. Merrick Senior Vice President, General Counsel, Secretary
Age: 73
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Debra P. Hellweg Vice President - Operations
Age: 43
Bio & Compensation  - Reuters
Kurt C. Wulff Vice President - Marketing
Age: 50
Bio & Compensation  - Reuters